Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Glioblastoma 6Rectal Neoplasms 5Oropharyngeal Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Burkitt Lymphoma 4Astrocytoma 4Urinary Bladder Neoplasms 3Mouth Neoplasms 3Glioma 3Carcinoma, Squamous Cell 3Adenocarcinoma of Lung 3Rhabdomyosarcoma 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Lymphoma, Follicular 2Laryngeal Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma 2Breast Carcinoma In Situ 2Adenocarcinoma, Bronchiolo-Alveolar 2Wilms Tumor 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1

Interventions

cemiplimab 2Blood Specimen Collection 2avelumab 1Sunscreening Agents 1Specimen Handling 1Radiotherapy 1Nivolumab 1Niacinamide 1Negative-Pressure Wound Therapy 1Ipilimumab 1Cryosurgery 1Cetuximab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Radiotherapy × 30 days × Clear all
NCT05574101 2026-05-15

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
34 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡